Doxycyclin

# Doxycyclin ## Overview - **Classification**: Tetracycline antibiotic - **Mechanism**: Reversibly binds to the 30S ribosomal subunit, inhibiting bacterial protein synthesis and growth. ## Primary Indications 1. **Bacterial Infections**: Broad-spectrum antibiotic for respiratory, urinary, skin, gastrointestinal, and sexually transmitted infections (e.g., Chlamydia, Gonorrhea). 2. **Rickettsial Infections**: Treatment of Rocky Mountain Spotted Fever, typhus, and other rickettsial diseases. 3. **Malaria Prophylaxis**: Prevention of malaria in travelers to endemic areas. 4. **Anthrax**: Treatment and post-exposure prophylaxis. 5. **Acne Vulgaris**: Management of moderate to severe inflammatory acne (lower doses). ## Adult Dosing ### Standard Dosing **General Bacterial Infections (e.g., Chlamydia, Mycoplasma pneumonia)** - **Dose**: **100 mg** - **Frequency**: Twice daily (every 12 hours) - **Route**: Oral (PO) or Intravenous (IV) - **Duration**: Typically 7-14 days, depending on infection **Rocky Mountain Spotted Fever (RMSF)** - **Dose**: **100 mg** - **Frequency**: Twice daily (every 12 hours) - **Route**: Oral (PO) or Intravenous (IV) - **Duration**: At least 3 days after fever subsides and clinical improvement, minimum 5-7 days. **Malaria Prophylaxis** - **Dose**: **100 mg** - **Frequency**: Once daily - **Route**: Oral (PO) - **Duration**: Start 1-2 days before travel, continue daily during travel, and for **4 weeks** after leaving endemic area. **Acne Vulgaris (oral formulations)** - **Dose**: **20 mg** - **Frequency**: Twice daily (every 12 hours) - **Route**: Oral (PO) - **Duration**: Long-term, several months ### Dose Adjustments - **Renal Impairment**: No dose adjustment generally required, as it is primarily excreted via the GI tract. - **Hepatic Impairment**: Use with caution. Monitor for increased adverse effects. - **Elderly Patients**: No specific dose adjustment needed based on age; monitor for tolerability and adverse effects. ## Pediatric Dosing ### Neonates (0-28 days) - Doxycycline is **generally not recommended** due to risk of permanent tooth discoloration and bone growth inhibition. - **Special Notes**: Only used in severe or life-threatening situations (e.g., anthrax, RMSF) when alternatives are contraindicated or ineffective. Close monitoring required. ### Infants (1-12 months) - Doxycycline is **generally not recommended** due to risk of permanent tooth discoloration and bone growth inhibition. - **Special Notes**: Reserved for severe, life-threatening infections (e.g., RMSF) when benefits outweigh risks and no safer alternative exists. ### Children (1-12 years) **For Severe/Life-Threatening Infections (e.g., RMSF, Anthrax)** - **Dose**: **2.2 mg/kg** - **Frequency**: Twice daily (every 12 hours) - **Route**: Oral (PO) or Intravenous (IV) - **Maximum**: **100 mg/dose** - **Special Notes**: Use only when benefits significantly outweigh risks of permanent tooth discoloration. Duration should be as short as possible. Oral suspension or capsule often preferred. ### Adolescents (13-18 years) - **Dose**: Use adult dosing: **100 mg** - **Frequency**: Twice daily (every 12 hours) - **Route**: Oral (PO) or Intravenous (IV) - **Maximum**: **200 mg/day** for most indications (up to **400 mg/day** for severe infections in divided doses). - **Special Notes**: Risk of tooth discoloration generally minimal after 8 years of age. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to tetracyclines. - **Absolute**: Pregnancy (Category D) and Breastfeeding (consider risk/benefit). - **Absolute**: Children under **8 years of age** (except for specific life-threatening indications like RMSF). ### Common Adverse Effects - **Very Common (>10%)**: Photosensitivity (sunburn-like reaction). - **Common (1-10%)**: Nausea, vomiting, diarrhea, esophageal irritation/ulceration, abdominal pain. - **Serious but Rare**: Pseudomembranous colitis (C. difficile), hepatotoxicity, severe skin reactions (e.g., SJS, TEN), benign intracranial hypertension. ### Key Drug Interactions - **Antacids (Al, Mg, Ca), Iron supplements, Bismuth subsalicylate**: Decreased doxycycline absorption. Separate administration by **2-3 hours**. - **Warfarin**: May potentiate anticoagulant effect. Monitor INR closely. - **Oral Contraceptives**: May reduce efficacy of hormonal contraception. Advise backup method. - **Penicillins**: May interfere with bactericidal effect of penicillins. Avoid concurrent use if possible. - **Retinoids (oral)**: Increased risk of benign intracranial hypertension. Avoid co-administration. ## Monitoring & Follow-up - **Before Treatment**: Assess liver function if pre-existing hepatic disease. - **During Treatment**: Monitor for GI upset, rash, photosensitivity, and signs of C. difficile. - **Clinical Signs**: Watch for persistent fever, severe headache (suggesting intracranial hypertension), yellowing of skin/eyes (hepatotoxicity), or severe watery diarrhea. ## Clinical Pearls - 💡 **Administration**: Take with a full glass of water and remain upright for at least 30 minutes to prevent esophageal irritation. - 💡 **Food**: Can be taken with food (especially dairy) to reduce GI upset, but food may slightly reduce absorption (often not clinically significant). - 💡 **Sun Protection**: Advise patients to use sunscreen and protective clothing due to high risk of photosensitivity. - 💡 **Expired Doxycycline**: **Never use expired tetracyclines**; they can degrade into nephrotoxic compounds (Fanconi-like syndrome). > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.